Therapy Areas: Infectious Diseases
Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens
4 March 2026 - Chinese biotechnology company Sino Biological Inc (SZ:301047) announced on Wednesday that it has launched the 2026-2027 Northern Hemisphere influenza vaccine strain antigens to accelera...
Novacyt completes acquisition of Southern Cross Diagnostics
2 March 2026 - Molecular diagnostics company Novacyt S.A. (EURONEXT GROWTH: ALNOV) (AIM: NCYT) announced on Monday that, further to its 23 February 2026 notification, its wholly owned subsidiary, Nova...
Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA
24 February 2026 - Late clinical-stage biotechnology company Armata Pharmaceuticals Inc (NYSE American:ARMP) announced on Monday that the US Food and Drug Administration (FDA) has granted Qualified In...
Beyfortus study shows sustained reduction in infant RSV hospitalisations across two seasons
16 February 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Monday that a universal respiratory syncytial virus immunisation programme using Beyfortus (nirse...
I Peace generates human iPS cells from NKT cells and offers them for research use
2 February 2026 - I Peace Inc, a California-based GMP cell therapy CDMO, announced on Friday that it has generated human induced pluripotent stem (iPS) cells from NKT cells and has started offering th...
Roivant to announce Q3 2026 financial results
26 January 2026 - Biopharmaceutical company Roivant (Nasdaq:ROIV) said on Friday that it will host a live conference call and webcast on Friday, 6 February 2026, to report its financial results for th...